Literature DB >> 11804378

Survival, quality of life and breast cancer.

P Mosconi1, M Colozza, M De Laurentiis, S De Placido, M Maltoni.   

Abstract

In recent years, evaluating quality of life (QoL) has become increasingly important as an additional measured outcome in cancer clinical trials, in particular in the field of breast cancer. This paper, after a general introduction to the present debate on the methodological issues involved in QoL evaluation, reviews results and open questions regarding the use of this measure in surgical, adjuvant and metastatic studies.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11804378     DOI： 10.1093/annonc/12.suppl_3.s15

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


  6 in total

1.  Influence of exercise activity on quality of life in long-term breast cancer survivors.

Authors:  Adam R Kendall; Maya Mahue-Giangreco; Catherine L Carpenter; Patricia A Ganz; Leslie Bernstein
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

2.  Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer.

Authors:  Iben Kümler; Vibeke Kirk Parner; Malgorzata K Tuxen; Bjørn Skjoldbye; Magnus Bergenfeldt; Knud Mejer Nelausen; Dorte Lisbet Nielsen
Journal:  Radiol Med       Date:  2015-01-09       Impact factor: 3.469

3.  Prognostic factors in 1,038 women with metastatic breast cancer.

Authors:  R Largillier; J-M Ferrero; J Doyen; J Barriere; M Namer; V Mari; A Courdi; J M Hannoun-Levi; F Ettore; I Birtwisle-Peyrottes; C Balu-Maestro; P Y Marcy; I Raoust; M Lallement; E Chamorey
Journal:  Ann Oncol       Date:  2008-07-17       Impact factor: 32.976

4.  Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.

Authors:  Amélie Darlix; Pierre-Jean Lamy; Evelyne Lopez-Crapez; Antoine Laurent Braccini; Nelly Firmin; Gilles Romieu; Simon Thezenas; William Jacot
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

Review 5.  Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.

Authors:  Ali Montazeri
Journal:  J Exp Clin Cancer Res       Date:  2008-08-29

6.  The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.

Authors:  Amélie Darlix; Christophe Hirtz; Simon Thezenas; Aleksandra Maceski; Audrey Gabelle; Evelyne Lopez-Crapez; Hélène De Forges; Nelly Firmin; Séverine Guiu; William Jacot; Sylvain Lehmann
Journal:  BMC Cancer       Date:  2019-01-30       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.